Advisor Group Holdings, Inc. Ironwood Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 135 shares of IRWD stock, worth $622. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135

Previous 1,489 90.93%

Holding current value

$622

Previous $9,000 100.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.93 - $7.04 $5,321 - $9,532	-1,354 Reduced 90.93%	135 $0
Q2 2024 Aug 13, 2024	SELL	$5.58 - $8.61 $8,615 - $13,293	-1,544 Reduced 50.91%	1,489 $9,000
Q1 2024 May 10, 2024	SELL	$8.32 - $15.45 $26,607 - $49,409	-3,198 Reduced 51.32%	3,033 $26,000
Q4 2023 Feb 12, 2024	SELL	$8.79 - $11.51 $768,826 - $1.01 Million	-87,466 Reduced 93.35%	6,231 $71,000
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $642,064 - $883,325	77,826 Added 490.37%	93,697 $902,000
Q2 2023 Aug 10, 2023	BUY	$10.1 - $11.6 $58,378 - $67,048	5,780 Added 57.28%	15,871 $168,000
Q1 2023 May 12, 2023	SELL	$10.37 - $12.56 $29,564 - $35,808	-2,851 Reduced 22.03%	10,091 $106,000
Q4 2022 Feb 10, 2023	SELL	$9.9 - $12.43 $21,393 - $26,861	-2,161 Reduced 14.31%	12,942 $160,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $1,064 - $1,299	105 Added 0.7%	15,103 $155,000
Q2 2022 Aug 10, 2022	BUY	$11.05 - $12.72 $143 - $165	13 Added 0.09%	14,998 $172,000
Q1 2022 May 04, 2022	BUY	$10.61 - $12.88 $72,593 - $88,124	6,842 Added 84.02%	14,985 $189,000
Q3 2021 Nov 05, 2021	BUY	$11.92 - $13.92 $70,661 - $82,517	5,928 Added 267.63%	8,143 $106,000
Q2 2021 Aug 02, 2021	BUY	$10.16 - $13.11 $5,791 - $7,472	570 Added 34.65%	2,215 $28,000
Q1 2021 May 13, 2021	SELL	$9.04 - $11.86 $6,427 - $8,432	-711 Reduced 30.18%	1,645 $18,000
Q4 2020 Feb 10, 2021	BUY	$9.05 - $12.2 $6,027 - $8,125	666 Added 39.41%	2,356 $28,000
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $8,001 - $9,558	-890 Reduced 34.5%	1,690 $15,000
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $22,292 - $29,194	2,439 Added 1729.79%	2,580 $27,000
Q1 2020 May 18, 2020	BUY	$8.58 - $14.01 $1,209 - $1,975	141 New	141 $2,000

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ironwood Pharmaceuticals Inc Transaction History